Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Adolescents
Clinical trial NCT02276612 · COMPLETED
Trial details
- NCT number
- NCT02276612
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-03
- Primary completion
- 2016-11-10
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.